Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.69 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Common Equity (2020 - 2026)

Updated

Cardiol Therapeutics' Common Equity came in at $17.37 million for Q2 2026, up 103.8% from $8.52 million a year earlier but down 1.6% from the prior quarter.

Analysis

Cardiol Therapeutics (CRDL) Common Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Cardiol Therapeutics' Common Equity was $12.8 million, down 29.2% from FY2024.

  • Common Equity has declined in each of the last four years, though with a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
  • Going back by year, Common Equity was $18.06 million in FY2024 (-12.9%), $20.75 million in FY2023 (-46.0%), $38.46 million in FY2022 (-36.8%) and $60.83 million in FY2021 (+514.1%).
  • The five-year range for quarterly Common Equity is $6.95 million (Q3 2025) to $60.48 million (Q4 2021).
  • Year-over-year, Common Equity increased in two of the last eight quarters, with an average decline of 2.0%.
  • The fastest year-over-year change in Common Equity over five years came in Q4 2021 (growth of 494.2%), and the weakest in Q3 2024 (a decline of 70.6%).
  • Business Quant data shows CRDL's Common Equity at $17.65 million (Q1 2026), $12.82 million (Q4 2025) and $6.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Cardiol Therapeutics 169.43 Mn 169.43 Mn - 17.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.37 Mn
Mar 31, 2026 17.65 Mn
Dec 31, 2025 12.82 Mn
Sep 30, 2025 6.95 Mn
Jun 30, 2025 8.52 Mn
Mar 31, 2025 12.26 Mn
Dec 31, 2024 17.70 Mn
Sep 30, 2024 7.65 Mn
Jun 30, 2024 11.23 Mn
Mar 31, 2024 14.89 Mn
Dec 31, 2023 20.75 Mn
Sep 30, 2023 26.01 Mn
Jun 30, 2023 28.85 Mn
Mar 31, 2023 33.70 Mn
Dec 31, 2022 38.46 Mn
Sep 30, 2022 44.99 Mn
Jun 30, 2022 49.30 Mn
Mar 31, 2022 54.64 Mn
Dec 31, 2021 60.48 Mn
Sep 30, 2021 23.11 Mn
API Access

Cardiol Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CRDL&period=max&api_key=YOUR_API_KEY